Novo Nordisk India launches ‘Break the Partnership’ between obesity and diabetes campaign
The campaign seeks to educate people with diabetes, their caregivers and doctors about the importance of managing weight in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA declines to approve Y-mAbs’s paediatric cancer drug
Y-mAbs said it is assessing the implications of the Food and Drug Administration's (FDA) Complete Response Letter (CRL) and the…
Roivant and Pfizer launch unit to develop inflammatory disease drug
The drug's efficacy as a treatment for ulcerative colitis is currently being assessed in a mid-stage study
The pandemic period gave us chance to see how effective public-private initiatives can be
COVID-19 brought with it lockdowns, social isolation, a crumbling of social support structures and highlighted the fissures in…
Why a National Drugs Database is important
The question remains, what are the plans to enforce such regulations more stringently?
With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients
Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…
UFlex showcases packaging solutions for pharma brands at CPHI & PMEC India 2022
At the expo, the company exhibited ‘fast-tear strip foil,’ ‘PET-based cold form blister,’ ‘Child-Resistant and Senior-Friendly…
Biocon Biologics completely acquires Viatris’s global biosimilars business
Biocon Biologics will recognise the combined revenue and associated profits from the acquired collaboration biosimilars with…
Pharma counterfeiting endangers public health and economy
Professor Bejon Kumar Misra, International Consumer Policy Expert, explains how even after becoming the 'pharmacy of the world,'…
Lupin launches Formoterol Fumarate inhalation solution in US
The company tends to market a generic equivalent of Perforomist Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty